Response of an ERBB2-Mutated Inflammatory Breast Carcinoma to Human Epidermal Growth Factor Receptor 2-Targeted Therapy

被引：41
作者：
Ali, Siraj M. [1 ]
Alpaugh, R. Katherine [2 ]
Downing, Sean R. [1 ]
Stephens, Philip J. [1 ]
Yu, Jian Q. [2 ]
Wu, Hong [2 ]
Buell, Jamie K. [1 ]
Miller, Vincent A. [1 ]
Lipson, Doron [1 ]
Palmer, Gary A. [1 ]
Ross, Jeffrey S. [1 ,3 ]
Cristofanilli, Massimo [2 ]
机构：
[1] Fdn Med, Cambridge, MA 02141 USA
[2] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[3] Albany Med Coll, Albany, NY 12208 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 25期
关键词：
KINASE MUTATIONS; CANCER;
D O I：
10.1200/JCO.2013.49.0599
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E88 / E91
页数：4
相关论文
共 9 条
  • [1] Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer
    Bose, Ron
    Kavuri, Shyam M.
    Searleman, Adam C.
    Shen, Wei
    Shen, Dong
    Koboldt, Daniel C.
    Monsey, John
    Goel, Nicholas
    Aronson, Adam B.
    Li, Shunqiang
    Ma, Cynthia X.
    Ding, Li
    Mardis, Elaine R.
    Ellis, Matthew J.
    [J]. CANCER DISCOVERY, 2013, 3 (02) : 224 - 237
  • [2] International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment
    Dawood, S.
    Merajver, S. D.
    Viens, P.
    Vermeulen, P. B.
    Swain, S. M.
    Buchholz, T. A.
    Dirix, L. Y.
    Levine, P. H.
    Lucci, A.
    Krishnamurthy, S.
    Robertson, F. M.
    Woodward, W. A.
    Yang, W. T.
    Ueno, N. T.
    Cristofanilli, M.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (03) : 515 - 523
  • [3] Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2
    Greulich, Heidi
    Kaplan, Bethany
    Mertins, Philipp
    Chen, Tzu-Hsiu
    Tanaka, Kumiko E.
    Yun, Cai-Hong
    Zhang, Xiaohong
    Lee, Se-Hoon
    Cho, Jeonghee
    Ambrogio, Lauren
    Liao, Rachel
    Imielinski, Marcin
    Banerji, Shantanu
    Berger, Alice H.
    Lawrence, Michael S.
    Zhang, Jinghui
    Pho, Nam H.
    Walker, Sarah R.
    Winckler, Wendy
    Getz, Gad
    Frank, David
    Hahn, William C.
    Eck, Michael J.
    Mani, D. R.
    Jaffe, Jacob D.
    Carr, Steven A.
    Wong, Kwok-Kin
    Meyerson, Matthew
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (36) : 14476 - 14481
  • [4] Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
    Piccart-Gebhart, MJ
    Procter, M
    Leyland-Jones, B
    Goldhirsch, A
    Untch, M
    Smith, I
    Gianni, L
    Baselga, J
    Bell, R
    Jackisch, C
    Cameron, D
    Dowsett, M
    Barrios, CH
    Steger, G
    Huang, CS
    Andersson, M
    Inbar, M
    Lichinitser, M
    Láng, I
    Nitz, U
    Iwata, H
    Thomssen, C
    Lohrisch, C
    Suter, TM
    Ruschoff, J
    Süto, T
    Greatorex, V
    Ward, C
    Straehle, C
    McFadden, E
    Dolci, MS
    Gelber, RD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (16) : 1659 - 1672
  • [5] Inflammatory Breast Cancer The Disease, the Biology, the Treatment
    Robertson, Fredika M.
    Bondy, Melissa
    Yang, Wei
    Yamauchi, Hideko
    Wiggins, Shannon
    Kamrudin, Samira
    Krishnamurthy, Savitri
    Le-Petross, Huong
    Bidaut, Luc
    Player, Audrey N.
    Barsky, Sanford H.
    Woodward, Wendy A.
    Buchholz, Thomas
    Lucci, Anthony
    Ueno, Naoto
    Cristofanilli, Massimo
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2010, 60 (06) : 351 - 375
  • [6] The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine (Publication with Expression of Concern)
    Ross, Jeffrey S.
    Slodkowska, Elzbieta A.
    Symmans, W. Fraser
    Pusztai, Lajos
    Ravdin, Peter M.
    Hortobagyi, Gabriel N.
    [J]. ONCOLOGIST, 2009, 14 (04) : 320 - 368
  • [7] A Unique Spectrum of Somatic PIK3CA (p110α) Mutations Within Primary Endometrial Carcinomas
    Rudd, Meghan L.
    Price, Jessica C.
    Fogoros, Sarah
    Godwin, Andrew K.
    Sgroi, Dennis C.
    Merino, Maria J.
    Bell, Daphne W.
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (06) : 1331 - 1340
  • [8] Intragenic ERBB2 kinase mutations in tumours
    Stephens, P
    Hunter, C
    Bignell, G
    Edkins, S
    Davies, H
    Teague, J
    Stevens, C
    O'Meara, S
    Smith, R
    Parker, A
    Barthorpe, A
    Blow, M
    Brackenbury, L
    Butler, A
    Clarke, O
    Cole, J
    Dicks, E
    Dike, A
    Drozd, A
    Edwards, K
    Forbes, S
    Foster, R
    Gray, K
    Greenman, C
    Halliday, K
    Hills, K
    Kosmidou, V
    Lugg, R
    Menzies, A
    Perry, J
    Petty, R
    Raine, K
    Ratford, L
    Shepherd, R
    Small, A
    Stephens, Y
    Tofts, C
    Varian, J
    West, S
    Widaa, S
    Yates, A
    Brasseur, F
    Cooper, CS
    Flanagan, AM
    Knowles, M
    Leung, SY
    Louis, DN
    Looijenga, LHJ
    Malkowicz, B
    Pierotti, MA
    [J]. NATURE, 2004, 431 (7008) : 525 - 526
  • [9] Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils
    Torti, Davide
    Trusolino, Livio
    [J]. EMBO MOLECULAR MEDICINE, 2011, 3 (11) : 623 - 636
1